Tumor necrosis factor-α does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning

Journal of Molecular and Cellular Cardiology

Volumn 37, Issue 1, 2004, Pages 51-61

  Dawn, Buddhadeb ^a   Guo, Yiru ^a   Rezazadeh, Arash ^a   Wang, Ou Li ^a   Stein, Adam B ^a   Hunt, Greg ^a   Varma, Jai ^a   Xuan, Yu Ting ^a   Wu, Wen Jian ^a   Tan, Wei ^a   Zhu, Xiaoping ^a   Bolli, Roberto ^a  

^a NONE

Author keywords

Activator protein 1; Late preconditioning; Myocardial infarction; Nuclear factor kappa B; Tumor necrosis factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN C FOS; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOPLASM; DNA BINDING; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HOMOZYGOSITY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; WILD TYPE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BLOTTING, WESTERN; CELL NUCLEUS; CYTOPLASM; CYTOSOL; DNA; HEMODYNAMIC PROCESSES; HOMOZYGOTE; IMMUNOHISTOCHEMISTRY; ISCHEMIA; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MICE; MICE, TRANSGENIC; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, CARDIAC; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; REPERFUSION INJURY; RISK; SIGNAL TRANSDUCTION; TEMPERATURE; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3142617357     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.03.012     Document Type: Article

References (58)

1. Kuzuya T., Hoshida S., Yamashita N., Fuji H., Oe H., Hori M., et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res. 72:1993;1293-1299
2. Bolli R. The late phase of preconditioning. Circ Res. 87:2000;972-983
3. Bolli R. The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: an overview. Basic Res Cardiol. 91:1996;57-63
4. Xuan Y.T., Tang X.L., Banerjee S., Takano H., Li R.C., Han H., et al. Nuclear factor-kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res. 84:1999;1095-1109
5. Xuan Y.T., Guo Y., Han H., Zhu Y., Bolli R. An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci USA. 98:2001;9050-9055
6. Bolli R., Dawn B., Tang X.L., Qiu Y., Ping P., Xuan Y.T., et al. The nitric oxide hypothesis of late preconditioning [editorial; see comments]. Basic Res Cardiol. 93:1998;325-338
7. Shinmura K., Tang X.L., Wang Y., Xuan Y.T., Liu S.Q., Takano H., et al. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA. 97:2000;10197-10202
8. Shinmura K., Bolli R., Liu S.Q., Tang X.L., Kodani E., Xuan Y.T., et al. Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circ Res. 91:2002;240-246
9. Torre-Amione G., Kapadia S., Lee J., Durand J.B., Bies R.D., Young J.B., et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation. 93:1996;704-711
10. Irwin M.W., Mak S., Mann D.L., Qu R., Penninger J.M., Yan A., et al. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation. 99:1999;1492-1498
11. Pagani F.D., Baker L.S., Hsi C., Knox M., Fink M.P., Visner M.S. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. J Clin Invest. 90:1992;389-398
12. Krown K.A., Page M.T., Nguyen C., Zechner D., Gutierrez V., Comstock K.L., et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest. 98:1996;2854-2865
13. Kurrelmeyer K.M., Michael L.H., Baumgarten G., Taffet G.E., Peschon J.J., Sivasubramanian N., et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci USA. 97:2000;5456-5461
14. Maekawa N., Wada H., Kanda T., Niwa T., Yamada Y., Saito K., et al. Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-alpha. J Am Coll Cardiol. 39:2002;1229-1235
15. Eddy L.J., Goeddel D.V., Wong G.H. Tumor necrosis factor-alpha pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun. 184:1992;1056-1059
16. Yamashita N., Hoshida S., Otsu K., Taniguchi N., Kuzuya T., Hori M. The involvement of cytokines in the second window of ischaemic preconditioning. Br J Pharmacol. 131:2000;415-422
17. Guo Y., Wu W.J., Qiu Y., Tang X.L., Yang Z., Bolli R. Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol. 275:1998;H1375-H1387
18. Guo Y., Jones W.K., Xuan Y.T., Tang X.L., Bao W., Wu W.J., et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA. 96:1999;11507-11512
19. Meldrum D.R., Meng X., Dinarello C.A., Ayala A., Cain B.S., Shames B.D., et al. Human myocardial tissue TNFalpha expression following acute global ischemia in vivo. J Mol Cell Cardiol. 30:1998;1683-1689
20. Deman J., Van Meurs M., Claassen E., Humblet C., Boniver J., Defresne M.P. In vivo expression of interleukin-1 beta (IL-1 beta), IL-2, IL-4, IL-6, tumour necrosis factor-alpha and interferon-gamma in the fetal murine thymus. Immunology. 89:1996;152-157
21. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acid Res. 11:1983;1475-1489
22. Ping P., Zhang J., Qiu Y., Tang X.L., Manchikalapudi S., Cao X., et al. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res. 81:1997;404-414
23. Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 46:1986;705-716
24. Lee W., Mitchell P., Tjian R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell. 49:1987;741-752
25. Wallenstein S., Zucker C.L., Fleiss J.L. Some statistical methods useful in circulation research. Circ Res. 47:1980;1-9
26. Gurevitch J., Frolkis I., Yuhas Y., Lifschitz-Mercer B., Berger E., Paz Y., et al. Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J Am Coll Cardiol. 30:1997;1554-1561
27. Bolli R., Bhatti Z.A., Tang X.L., Qiu Y., Zhang Q., Guo Y., et al. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res. 81:1997;42-52
28. Qiu Y., Rizvi A., Tang X.L., Machikalapudi S., Takano H., Jadoon A.K., et al. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol. 273:1997;H2931-H2936
29. Takano H., Tang X.L., Qiu Y., Guo Y., French B.A., Bolli R. Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ Res. 83:1998;73-84
30. Banerjee S., Tang X.L., Qiu Y., Takano H., Manchikalapudi S., Dawn B., et al. Nitroglycerin induces late preconditioning against myocardial stunning via a PKC-dependent pathway. Am J Physiol. 277:1999;H2488-H2494
31. Kalra D., Baumgarten G., Dibbs Z., Seta Y., Sivasubramanian N., Mann D.L. Nitric oxide provokes tumor necrosis factor-alpha expression in adult feline myocardium through a cGMP-dependent pathway. Circulation. 102:2000;1302-1307
32. Peng T., Lu X., Lei M., Feng Q. Endothelial nitric-oxide synthase enhances lipopolysaccharide-stimulated tumor necrosis factor-alpha expression via cAMP-mediated p38 MAPK pathway in cardiomyocytes. J Biol Chem. 278:2003;8099-8105
33. Kodani E., Xuan Y.T., Takano H., Shinmura K., Tang X.L., Bolli R. Role of cyclic guanosine monophosphate in late preconditioning in conscious rabbits. Circulation. 105:2002;3046-3052
34. Barna M., Komatsu T., Reiss C.S. Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection. Virology. 223:1996;331-343
35. Barsacchi R., Perrotta C., Bulotta S., Moncada S., Borgese N., Clementi E. Activation of endothelial nitric-oxide synthase by tumor necrosis factor-alpha: a novel pathway involving sequential activation of neutral sphingomyelinase, phosphatidylinositol-3′ kinase, and Akt. Mol Pharmacol. 63:2003;886-895
36. Xuan Y.T., Tang X.L., Qiu Y., Banerjee S., Takano H., Han H., et al. Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol. 279:2000;H2360-H2371
37. Frangogiannis N.G., Lindsey M.L., Michael L.H., Youker K.A., Bressler R.B., Mendoza L.H., et al. Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation. 98:1998;699-710
38. Baldwin A.S. Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 14:1996;649-683
39. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. 18:2000;621-663
40. Lander H.M., Sehajpal P., Levine D.M., Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J Immunol. 150:1993;1509-1516
41. Satriano J., Schlondorff D. Activation and attenuation of transcription factor NF-kB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3′:5′-cyclic monophosphate. Evidence for involvement of reactive oxygen species. J Clin Invest. 94:1994;1629-1636
42. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 87:1990;1620-1624
43. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem. 266:1991;4244-4250
44. Baud V., Karin M. Signal transduction by tumor necrosis factor and its relatives. Trend Cell Biol. 11:2001;372-377
45. Baeuerle P.A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 12:1994;141-179
46. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10:1991;2247-2258
47. Xie Q.W., Whisnant R., Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med. 177:1993;1779-1784
48. Balligand J.L., Ungureanu-Longrois D., Simmons W.W., Pimental D., Malinski T.A., Kapturczak M., et al. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem. 269:1994;27580-27588
49. Gross S.S., Wolin M.S. Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol. 57:1995;737-769
50. Yamamoto K., Arakawa T., Ueda N., Yamamoto S. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem. 270:1995;31315-31320
51. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1072:1991;129-157
52. Shaulian E., Karin M. AP-1 in cell proliferation and survival. Oncogene. 20:2001;2390-2400
53. Halazonetis T.D., Georgopoulos K., Greenberg M.E., Leder P. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell. 55:1988;917-924
54. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. 270:1995;16483-16486
55. Brand T., Sharma H.S., Fleischmann K.E., Duncker D.J., McFalls E.O., Verdouw P.D., et al. Proto-oncogene expression in porcine myocardium subjected to ischemia and reperfusion. Circ Res. 71:1992;1351-1360
56. Chandrasekar B., Freeman G.L. Induction of nuclear factor kappaB and activation protein 1 in postischemic myocardium. FEBS Lett. 401:1997;30-34
57. Diaz-Guerra M.J., Velasco M., Martin-Sanz P., Bosca L. Evidence for common mechanisms in the transcriptional control of type II nitric oxide synthase in isolated hepatocytes. Requirement of NF-kappaB activation after stimulation with bacterial cell wall products and phorbol esters. J Biol Chem. 271:1996;30114-30120
58. Miller C., Zhang M., He Y., Zhao J., Pelletier J.P., Martel-Pelletier J., et al. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins. J Cell Biochem. 69:1998;392-413